N. Blijlevens

Engineering of CD34+ progenitor-derived natural killer cells with higher-affinity CD16a for enhanced antibody-dependent cellular cytotoxicity.

H. Dolstra, Jianming Wu, P. D. de Jonge, 2023, Cytotherapy.

Reproductive outcomes and reproductive health care utilization among male survivors of childhood cancer: A DCCSS‐LATER study

C. Beerendonk, E. Dulmen‐den Broeder, J. Loonen, 2023, Cancer.